Is Cannabis A Last-Resort Therapy in Psychiatry for Mood Disorders? 

The role of cannabis as a last-resort therapy is often discussed in psychiatric care, particularly for patients who have not responded to standard treatments. For those living with mood disorders  such as depression or bipolar disorder, cannabis is sometimes considered when multiple lines of therapy have failed. In this context, patients with a mental health condition  may view cannabis as a potential salvage option rather than a first-choice treatment. 

Although anecdotal evidence points to benefits, strong clinical data supporting cannabis as a tertiary therapy remain limited. 

Cannabis At the End of Treatment Pathways 

When examining cannabis as a last resort, clinicians often weigh its place alongside other treatments that have not produced results. The following points illustrate its potential role at later stages of care. 

Last-Line Cannabis Treatment 

The idea of last-line cannabis treatment reflects cases where patients turn to cannabis after exhausting options like SSRIs, mood stabilisers, or psychotherapy. 

Salvage Therapy and Cannabis 

Some specialists describe salvage therapy and cannabis as an approach for individuals who have not found relief elsewhere, though its use is highly individualised. 

Tertiary Treatment Cannabis 

The term tertiary treatment cannabis highlights its status as an emerging, rather than established, option in psychiatry, used cautiously and often within private care settings. 

In summary, while cannabis as a last-resort therapy may offer hope to some, it should be approached with careful oversight due to limited evidence and potential risks in mood disorders. 

For patients exploring final-line treatment strategies, providers like LeafEase can offer supportive consultations tailored to safe and evidence-informed decisions. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Mood Disorders.